|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
110.12(B) |
Last
Volume: |
7,714,820 |
Avg
Vol: |
8,368,014 |
52
Week Range: |
$48.64 - $77.71 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
304,513 |
421,705 |
996,293 |
2,118,674 |
Total Sell Value |
$22,679,618 |
$30,048,564 |
$60,765,476 |
$110,963,213 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
14 |
25 |
43 |
79 |
End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fleishman Joel Lawrence |
officerTitle |
|
2006-01-09 |
4 |
A |
$10.44 |
$83,520 |
D/D |
8,000 |
96,567 |
|
- |
|
Nicholas Nicholas J Jr |
Director |
|
2006-01-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,000 |
62,466 |
|
- |
|
Pucel Kenneth |
officerTitle |
|
2006-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(722) |
7,947 |
|
- |
|
Russell Mary E |
officerTitle |
|
2006-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(797) |
4,706 |
|
- |
|
Mario Ernest |
officerTitle |
|
2005-12-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
400 |
16,700 |
|
- |
|
Mario Ernest |
officerTitle |
|
2005-12-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
400 |
111,167 |
|
- |
|
Russell Mary E |
officerTitle |
|
2005-12-19 |
4 |
AS |
$25.52 |
$153,120 |
D/D |
(6,000) |
0 |
|
- |
|
Russell Mary E |
officerTitle |
|
2005-12-19 |
4 |
OE |
$12.50 |
$75,000 |
D/D |
6,000 |
6,000 |
|
- |
|
Sandman Paul W |
officerTitle |
|
2005-11-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
398 |
32,721 |
|
- |
|
Russell Mary E |
SVP and CMO |
|
2005-08-03 |
4 |
AS |
$28.50 |
$741,000 |
D/D |
(26,000) |
0 |
|
- |
|
Russell Mary E |
SVP and CMO |
|
2005-08-03 |
4 |
OE |
$6.66 |
$243,150 |
D/D |
26,000 |
26,000 |
|
- |
|
Mario Ernest |
Director |
|
2005-06-10 |
4 |
OE |
$12.34 |
$47,484 |
D/D |
2,668 |
111,567 |
|
- |
|
Moreci Stephen F |
Sr. VP, Endosurgery |
|
2005-05-31 |
4 |
S |
$27.25 |
$1,433,547 |
D/D |
(52,500) |
206 |
|
- |
|
Moreci Stephen F |
Sr. VP, Endosurgery |
|
2005-05-31 |
4 |
OE |
$8.50 |
$729,463 |
D/D |
52,500 |
52,706 |
|
- |
|
Burns Brian R |
SVP - Quality |
|
2005-05-16 |
4 |
AS |
$30.26 |
$356,087 |
D/D |
(11,666) |
1,289 |
|
- |
|
Burns Brian R |
SVP - Quality |
|
2005-05-16 |
4 |
OE |
$6.66 |
$198,450 |
D/D |
11,666 |
12,955 |
|
- |
|
Nicholas Peter M |
Director |
|
2005-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
104,645,988 |
|
- |
|
Abele John E |
Director |
|
2005-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
54,265,500 |
|
- |
|
Reinhardt Uwe E |
Director |
|
2005-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
18,000 |
|
- |
|
Pepper John E |
Director |
|
2005-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
30,000 |
|
- |
|
Fleishman Joel Lawrence |
Director |
|
2005-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
88,567 |
|
- |
|
Laviolette Paul A |
SVP & Group President |
|
2005-05-05 |
4 |
AS |
$29.15 |
$7,320,627 |
D/D |
(250,000) |
33,854 |
|
- |
|
Laviolette Paul A |
SVP & Group President |
|
2005-05-05 |
4 |
OE |
$6.94 |
$1,734,375 |
D/D |
250,000 |
283,854 |
|
- |
|
Laviolette Paul A |
SVP & Group President |
|
2005-05-04 |
4 |
AS |
$29.35 |
$4,404,720 |
D/D |
(150,000) |
33,854 |
|
- |
|
Laviolette Paul A |
SVP & Group President |
|
2005-05-04 |
4 |
OE |
$6.94 |
$1,040,625 |
D/D |
150,000 |
183,854 |
|
- |
|
1823 Records found
|
|
Page 72 of 73 |
|
|